Research & Development

Cordyceps Militaris Fungus Offers Promising New Avenue for Cancer Treatment
Research & Development Cordyceps Militaris Fungus Offers Promising New Avenue for Cancer Treatment

In the world of modern medicine, finding innovative, safer, and more effective treatments for cancer remains a relentless pursuit. Researchers from the University of Nottingham have turned their attention to an unassuming yet potent ally in this fight—the parasitic fungus Cordyceps militaris. S

Advancements and Challenges of AAV Vectors in Gene Therapy Trials
Research & Development Advancements and Challenges of AAV Vectors in Gene Therapy Trials

Gene therapy has emerged as a revolutionary approach to treating genetic disorders by delivering therapeutic genetic material directly into patients' cells. Among the various vectors used for gene delivery, Adeno-Associated Virus (AAV) vectors have gained significant attention due to their

How Is Simoa Revolutionizing Alzheimer’s Diagnosis and Treatment?
Research & Development How Is Simoa Revolutionizing Alzheimer’s Diagnosis and Treatment?

The landscape of Alzheimer’s disease (AD) diagnosis and treatment is undergoing a significant transformation thanks to the groundbreaking Simoa® technology by Quanterix. This ultra-sensitive immunoassay platform is reshaping how biomarkers are identified and validated, offering new possibilities fo

Transforming Cancer Research with Patient-Derived Organoid Innovation
Research & Development Transforming Cancer Research with Patient-Derived Organoid Innovation

Cancer research has entered a new era with the advent of patient-derived organoids (PDOs). These sophisticated three-dimensional (3D) models, grown from patient cells, have revolutionized our understanding of tumors and their microenvironments. By mimicking the complexity of human tumors, PDOs have

AstraZeneca Seeks FDA Approval for EGFR-Mutant NSCLC Therapy
Research & Development AstraZeneca Seeks FDA Approval for EGFR-Mutant NSCLC Therapy

AstraZeneca has recently submitted a Biologics License Application (BLA) to the FDA for datopotamab deruxtecan (Dato-DXd), targeting accelerated approval for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that possess EGFR mutations. This submission is a significant

Can MassiveFold Revolutionize Protein Structure Prediction Speed?
Research & Development Can MassiveFold Revolutionize Protein Structure Prediction Speed?

The quest for faster and more efficient protein structure prediction has taken a significant leap forward with the advent of MassiveFold, a new iteration of AlphaFold designed for parallel processing. Within the realm of molecular biology and drug discovery, the speed and accuracy of protein

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later